Anti-Cancer Drugs
Impact Factor & Key Scientometrics

Anti-Cancer Drugs
Overview

Impact Factor

2.248

H Index

96

Impact Factor

2.27

I. Basic Journal Info

Country

United States
Journal ISSN: 09594973, 14735741
Publisher: Lippincott Williams & Wilkins Ltd.
History: 1990-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Anti-Cancer Drugs
Impact Factor by Web of Science

Index

SCIE/SSCI

Impact Factor

2.248

by WOS

Ranking

6972

by WOS

Anti-Cancer Drugs
SJR, SJR Impact Factor and H Index

H Index

96

SJR

0.651

Scopus Impact Factor

2.27

Anti-Cancer Drugs
SJR Impact Factor 2-year, 3-year, 4-year

2-year
Impact Factor

2.27

3-year
Impact Factor

2.381

4-year
Impact Factor

2.27

Scope/Description:

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy.

II. Science Citation Report (SCR)



Anti-Cancer Drugs
SCR Impact Factor

Anti-Cancer Drugs
SCR Journal Ranking

Anti-Cancer Drugs
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

0.651

Anti-Cancer Drugs
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Anti-Cancer Drugs
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Anti-Cancer Drugs
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Anti-Cancer Drugs
Impact Factor History

2-year 3-year 4-year
  • 2021 Impact Factor
    2.27 2.381 2.51
  • 2020 Impact Factor
    2.101 2.289 2.131
  • 2019 Impact Factor
    2.362 2.142 2.056
  • 2018 Impact Factor
    1.87 2.015 2.074
  • 2017 Impact Factor
    1.773 2.033 2.077
  • 2016 Impact Factor
    2.513 2.436 2.291
  • 2015 Impact Factor
    2.398 2.271 2.229
  • 2014 Impact Factor
    2.065 NA NA
  • 2013 Impact Factor
    2.25 NA NA
  • 2012 Impact Factor
    2.795 NA NA
  • 2011 Impact Factor
    2.663 NA NA
  • 2010 Impact Factor
    2.504 NA NA
  • 2009 Impact Factor
    2.623 NA NA
  • 2008 Impact Factor
    2.635 NA NA
  • 2007 Impact Factor
    2.679 NA NA
  • 2006 Impact Factor
    2.791 NA NA
  • 2005 Impact Factor
    2.122 NA NA
  • 2004 Impact Factor
    2.311 NA NA
  • 2003 Impact Factor
    2.185 NA NA
  • 2002 Impact Factor
    2.214 NA NA
  • 2001 Impact Factor
    1.649 NA NA
  • 2000 Impact Factor
    1.578 NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Anti-Cancer Drugs
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

96

Anti-Cancer Drugs
H-Index History